NASDAQ:NVAX

Novavax Stock Predictions

etoro logo Buy NVAX
*Your capital is at risk
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

NVAX Prediction Chart

NVAX Predictions History

Latest community submissions for NVAX.
Predictor Target Session Target Price Result Direction Accuracy Score
Andrey A Andrey A @AndreyA.173616
Sep 14, 2020 Bullish $105.80 X 1
JS JS Pro
Sep 14, 2020 $97.52 -7.83% $105.80 X 92.17% 1
iHustle84 iHustle84 Pro
Sep 14, 2020 $97.89 -7.48% $105.80 X 92.52% 1
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Sep 8, 2020 $92.39 +8.30% $85.31 X 91.70% 1
iHustle84 iHustle84 Pro
Sep 8, 2020 $90.00 +5.50% $85.31 X 94.50% 1
JS JS Pro
Sep 8, 2020 $87.40 +2.45% $85.31 X 97.55% 1
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Aug 21, 2020 $126.84 -7.83% $137.62 X 92.17% 1
JS JS Pro
Aug 21, 2020 $140.51 +2.10% $137.62 X 97.90% 1
2poJeff 2poJeff Pro
Aug 21, 2020 $146.30 +6.31% $137.62 X 93.69% 1
R R @R.167493
Aug 14, 2020 Bearish $146.51 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NVAX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NOVAVAX INC
Novavax
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE